|
🐬
|
Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety.
P. Cohen,
G. Bright,
A. Rogol,
A. Kappelgaard,
R. Rosenfeld
|
7 |
2002 |
7
🐬
|
|
🦁
|
Organ-specific autoantibodies in children with common endocrine diseases.
G. Bright,
R. Blizzard,
D. Kaiser,
W. Clarke
|
7 |
1982 |
7
🦁
|
|
🦁
|
Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey.
G. Bright
|
6 |
2008 |
6
🦁
|
|
🐬
|
Age of thelarche and menarche in contemporary US females: a cross-sectional analysis
S. Cabrera,
G. Bright,
J. Frane,
S. Blethen,
Peter A. Lee
|
6 |
2014 |
6
🐬
|
|
🐬
|
Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
P. Cohen,
A. Rogol,
C. Howard,
G. Bright,
A. Kappelgaard,
R. Rosenfeld
|
6 |
2007 |
6
🐬
|
|
🦁
|
Failure of Cortisol Blockade to Inhibit Early Morning Increases in Basal Insulin Requirements in Fasting Insulin-dependent Diabetics
G. Bright,
T. Melton,
A. Rogol,
W. Clarke
|
6 |
1980 |
6
🦁
|
|
🐢
|
Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.
L. Midyett,
A. Rogol,
A. Rogol,
Quentin Lee Van Meter,
J. Frane,
G. Bright
|
6 |
2010 |
6
🐢
|
|
🐬
|
[Insulin growth factor-I-based dosing of growth hormone therapy in children: a randomized, controlled study].
Pinchas Cohen,
A. Rogol,
C. Howard,
G. Bright,
A. Kappelgaard,
R. Rosenfeld
|
6 |
2009 |
6
🐬
|
|
🐬
|
Autoimmunity in congenital rubella syndrome.
W. Clarke,
K. Shaver,
G. Bright,
A. Rogol,
W. Nance
|
5 |
1984 |
5
🐬
|
